Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder

  • Author: Frederick L. Altice, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 2/5/20 (What's New)

Summary

  • Drug interactions between opioid substitution therapy and antiretroviral medications may result in increased toxicity or reduced efficacy of ART or in clinical opioid withdrawal or overdose
    • NRTIsNNRTIs
      PIs
        Lopinavir/Ritonavir
          Tipranavir
            Atazanavir
              Darunavir
              Integrase Inhibitors
                Entry Inhibitors
                  Other Common Nonantiretroviral HIV Medications

                  Action required

                  Keywords: Initial Antiretroviral Therapy, IV Drug Use, Special Populations

                  ©2020 Clinical Care Options, LLC. All Rights Reserved.

                  The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.